Cargando…
Regulations and guidelines governing stem cell based products: Clinical considerations
The use of stem cells as medicines is a promising and upcoming area of research as they may be able to help the body to regenerate damaged or lost tissue in a host of diseases like Parkinson′s, multiple sclerosis, heart disease, liver disease, spinal cord damage, cancer and many more. Translating ba...
Autor principal: | George, Bobby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159216/ https://www.ncbi.nlm.nih.gov/pubmed/21897884 http://dx.doi.org/10.4103/2229-3485.83228 |
Ejemplares similares
-
Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010) -
Registration of Medical Devices
por: George, Bobby
Publicado: (2010) -
Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013) -
China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022) -
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)